The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Open accessAbstract
Assessment of Alzheimer's disease (AD)-related neurofibrillary pathology requires a procedure that permits a sufficient differentiation between initial, intermediate, and late stages. The gradual deposition of a hyperphosphorylated tau protein within select neuronal types in specific nuclei or areas is central to the disease process. The staging of AD-related neurofibrillary pathology originally described in 1991 was performed on unconventionally thick sections (100 mum) using a modern silver technique and reflected the progress of the disease process based chiefly on the topographic expansion of the lesions. To better meet the demands of routine laboratories this procedure is revised here by adapting tissue selection and processing to the needs of paraffin-embedded sections (5-15 mum) and by introducing a robust immunoreaction (AT8) for hyperphosphorylated tau protein that can be processed on an automated basis. It is anticipated that this revised methodological protocol will enable a more uniform application of the staging procedure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accumulation of Aβ plaques and NFTs follows distinct regional progressions across brain regions as AD advances.”
From National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2012) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with the stereotypical hierarchical accumulation of NFTs along neural networks20,21”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They were categorized into the stage C of amyloid deposition and the stage VI of neurofibrillary degeneration, following the Braak's staging (13).”
From Microglia express ABI3 in the brains of Alzheimer's disease and Nasu-Hakola disease (2017) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“by definition, the primary visual cortex (V1 region) bears NFTs only in Braak NFT stage VI20,21”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“we rank ordered the five brain regions based on their known vulnerability to neurofibrillary degeneration20,21 (that is, EC > ITG > PFC > V2 > V1)”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“the distinguishing feature between Braak NFT stages V and VI is not just the presence of NFTs in the primary visual (V1), motor and sensory cortical areas, but more severe neurofibrillary degeneration21 and atrophy throughout the cortical mantle51”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [2]
In the citing paper
“We consider it to be an important clue that most brains from elderly human subjects show abnormalities that fall somewhere along particular continua of pathologic severity (60, 96-100).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citationNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Self-citationFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Self-citationHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
(1964) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,411
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Delacourte, A., David, J. P., Sergeant, N., Buée, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999) · Neurology · doi:10.1212/wnl.52.6.1158 · Cited by 828
Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769
Self-citationGeddes, J. F. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.9.798-a · Cited by 725
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 721
über eigenartige Krankheitsfälle des späteren Alters
Alzheimer, A. (1911) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02866241 · Cited by 712
Arriagada, P. V., Marzloff, K., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.9.1681 · Cited by 638
Neuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen, R. C., Parisi, J. E., Dickson, D. W., Johnson, K. A., Knopman, D. S., Boeve, B. F., Jicha, G. A., Ivnik, R. J., Smith, G. E., Tangalos, E. G., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.665 · Cited by 616
Self-citationMonoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608
Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections
Braak, H., & Braak, E. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00661.x · Cited by 598
Self-citation(1994) · Toxicology and Industrial Health · doi:10.1177/074823379401000603 · Cited by 501
Biernat, J., Mandelkow, E. M., Schröter, C., Lichtenberg‐Kraag, B., Steiner, B., Berling, B., Meyer, H., Mercken, M., Vandermeeren, A., & Goedert, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05204.x · Cited by 484
Entorhinal cortex pathology in Alzheimer's disease
van Hoesen, G. W., Hyman, B. T., & Damasio, A. R. (1991) · Hippocampus · doi:10.1002/hipo.450010102 · Cited by 475
Braak, H., Braak, E., Grundke-Iqbal, I., & Iqbal, K. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90288-0 · Cited by 432
Self-citationSilver staining of Alzheimer's neurofibrillary changes by means of physical development.
Gallyas, F. (1971) · PubMed · Cited by 411
Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00062-6 · Cited by 410
Self-citationMercken, M. H., Vandermeeren, M., Lübke, U., Six, J., Boons, J., VOORDE, A. V. D., Martin, J., & Gheuens, J. (1992) · Acta Neuropathologica · doi:10.1007/bf00227819 · Cited by 356
The Molecular and Genetic Basis of Neurological Disease
Trojanowski, J. Q. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199309000-00013 · Cited by 341
The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases
Braak, H., & Braak, E. (1992) · Neuroscience Research · doi:10.1016/0168-0102(92)90014-4 · Cited by 334
Self-citationBancher, C., Braak, H., Fischer, P. A., & Jellinger, K. A. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90590-h · Cited by 325
Self-citationYamamoto, T., & Hirano, A. (1986) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1986.tb00677.x · Cited by 320
Newell, K. L., Hyman, B. T., Growdon, J. H., & Hedley-Whyte, E. T. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199911000-00004 · Cited by 289
Neurodegenerative disorders with extensive tau pathology: A comparative study and review
Feany, M. Β., & Dickson, D. W. (1996) · Annals of Neurology · doi:10.1002/ana.410400204 · Cited by 280
Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology
Schönheit, B., Zarski, R., & Ohm, T. G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.09.009 · Cited by 262
Memory and mental status correlates of modified Braak staging
Grober, E. H., Dickson, D. W., Sliwinski, M. J., Herman Buschke, L., Katz, M., Crystal, H., & Lipton, R. B. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00063-9 · Cited by 235
Ohm, T. G., Müller, H., Braak, H., & Böhl, J. (1995) · Neuroscience · doi:10.1016/0306-4522(95)90397-p · Cited by 222
Self-citationREVIEW: tau protein pathology in Alzheimer’s disease and related disorders
Tolnay, M., & Probst (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00182.x · Cited by 214
Chapter 32 Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease
Hoesen, G. W. V., & Hyman, B. T. (1990) · Progress in brain research · doi:10.1016/s0079-6123(08)61268-6 · Cited by 201
Goedert, M. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0466 · Cited by 180
Braak, H., Braak, E., Ohm, T. G., & Böhl, J. (1988) · Stain Technology · doi:10.3109/10520298809107184 · Cited by 171
Self-citationThal, D. R., Holzer, M., Rüb, U., Waldmann, G., Günzel, S., Zedlick, D., & Schober, R. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7380 · Cited by 165
Cras, P. P., Smith, M. A., Richey, P. L., Siedlak, S. L., Mulvihill, P., & Perry, G. L. (1995) · Acta Neuropathologica · doi:10.1007/bf00309621 · Cited by 156
Vulnerability of Select Neuronal Types to Alzheimer's Disease
BRAAK, H., DEL TREDICI, K., SCHULTZ, C., & BRAAK, E. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05560.x · Cited by 150
Self-citationModeling the Relation Between Neurofibrillary Tangles and Intellectual Status
Duyckaerts, C. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)80306-5 · Cited by 150
Neurodegeneration in Normal Brain Aging and Disease
Thal, D. R., Del Tredici, K., & Braak, H. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.23.pe26 · Cited by 149
Self-citationThe Neuropathological Diagnosis of Alzheimer’s Disease: Clinical-Pathological Studies
Hyman, B. T. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00066-3 · Cited by 145
Braak, E., & Braak, H. (1997) · Acta Neuropathologica · doi:10.1007/s004010050622 · Cited by 143
Self-citationFallacies in the pathological confirmation of the diagnosis of Alzheimer's disease
Bowler, J. V., Muñoz, D. G., Merskey, H., & Hachinski, V. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.1.18 · Cited by 132
Pathology of Alzheimer's Disease
Blass, J. P., Ko, B., & Wisniewski, H. M. (1991) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30315-0 · Cited by 132
Clinical validity of Braak neuropathological staging in the oldest-old
Gold, G., Bouras, C., Kövari, E., Canuto, A., González Glaría, B., Malky, A., Hof, P. R., Michel, J.-P., & Giannakopoulos, P. (2000) · Acta Neuropathologica · doi:10.1007/s004010051163 · Cited by 128
Alafuzoff, I., Pikkarainen, M., Al-Sarraj, S., Arzberger, T., Bell, J., Bodi, I., Bogdanovic, N., Budka, H., Bugiani, O., Ferrer, I., et al. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229986.17548.27 · Cited by 117
Self-citationRecognition memory span in rhesus monkeys of advanced age
Moss, M. B., Killiany, R., Lai, Z. C., Rosene, D. L., & Herndon, J. G. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00211-4 · Cited by 117
Cellular pathology of the central nervous system.
Graeber, M. B., Blakemore, W. F., & Kreutzberg, G. W. (2002) · Max Planck Institute for Plasma Physics · Cited by 111
Prevalence, incidence and duration of Braak's stages in the general population: can we know?
Duyckaerts, C., & Hauw, J.-J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00047-x · Cited by 109
Smithson, K. G., MacVicar, B. A., & Hatton, G. I. (1983) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(83)90016-x · Cited by 105
Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease
Geddes, J. W., Tekirian, T. L., Soultanian, N. S., Ashford, J. W., Davis, D. G., & Markesbery, W. R. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00063-8 · Cited by 101
The neuropathological diagnosis of Alzheimer disease
Jellinger, K. A. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_9 · Cited by 97
Temporal Sequence of Alzheimer’s Disease-Related Pathology
Braak, H., & Braak, E. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_14 · Cited by 95
Self-citationAlzheimer?s disease: intraneuronal alterations precede insoluble amyloid-$beta; formation
Braak, H., & Tredici, K. D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.015 · Cited by 93
Self-citationRelationship between plaques, tangles, and dystrophic processes in Alzheimer's disease
Trojanowski, J. Q., Shin, R., Schmidt, M. L., & Lee, V. M.-Y. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00176-2 · Cited by 89
Light Insensitive Physical Developers
Gallyas, F. (1979) · Stain Technology · doi:10.3109/10520297909112679 · Cited by 83
Lamy, C., Duyckaerts, C. J., Delaère, P., PAYAN, C., Fermanian, J., Poulain, V., & Hauw, J. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01255.x · Cited by 81
Schmidt, M. L., Lee, V. M., & Trojanowski, J. Q. (1991) · PubMed · Cited by 81
Nagy, Z., Hindley, N., Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., Barnetson, L. P. D., KING, E., Jobst, K. A., & Smith, A. D. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017111 · Cited by 78
Self-citationThe Neurofibrillary Pathology of Alzheimer's Disease
Goedert, M. (1997) · The Neuroscientist · doi:10.1177/107385849700300212 · Cited by 77
Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease
Markesbery, W. R. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00064-x · Cited by 75
Hyman, B. T., & Gómez‐Isla, T. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90031-0 · Cited by 74
New Neuropathological Criteria for Alzheimer Disease
Hyman, B. T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1174 · Cited by 73
Gertz, H., Xuereb, J. H., Huppert, F. A., Brayne, C., McGee, M. A., Paykel, E. S., Harrington, C. R., Mukaetova-Ladinska, E., Arendt, T., & Wischik, C. M. (1998) · Acta Neuropathologica · doi:10.1007/s004010050780 · Cited by 69
Boller, F., & Cappa, S. F. (2001) · Elsevier eBooks · Cited by 69
McKeel, D. W., Price, J. L., Miller, J. P., Grant, E. A., Xiong, C., Berg, L., & Morris, J. C. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.10.1028 · Cited by 68
Uchihara, T., Nakamura, A., Yamazaki, M., & Mori, O. (2001) · Acta Neuropathologica · doi:10.1007/s004010000306 · Cited by 68
Gallyas, F., & Wolff, J. R. (1986) · Journal of Histochemistry & Cytochemistry · doi:10.1177/34.12.3537114 · Cited by 67
Diagnosis and Staging of Alzheimer Disease
Duyckaerts, C. J., & Hauw, J. J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00067-5 · Cited by 65
The Molecular and Genetic Basis of Neurological Disease
Albin, R. L. (1997) · JAMA · doi:10.1001/jama.1997.03550070091049 · Cited by 65
Diagnostic criteria for Alzheimer's disease.
Price, J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00072-9 · Cited by 64
Practical measures to simplify the Braak tangle staging method for routine pathological screening
Harding, A. J., Kril, J. J., & Halliday, G. M. (2000) · Acta Neuropathologica · doi:10.1007/pl00007425 · Cited by 58
Iqbal, K., Braak, E., Braak, H., Zaidi, T., & Grundke, I. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90022-c · Cited by 57
Self-citationHalliday, G., Ng, T., Rodriguez, M., Harding, A., Blumbergs, P., Evans, W., Fabian, V., Fryer, J., Gonzales, M., Harper, C., et al. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0529-5 · Cited by 57
Silver Labeling of Alzheimer Neurofibrillary Changes and Brain β-Amyloid
Iqbal, K., Braak, H., Braak, E., & Grundke, I. (1993) · Journal of Histotechnology · doi:10.1179/his.1993.16.4.335 · Cited by 52
Self-citationNagy, Z., Yilmazer-Hanke, D. M., Braak, H., Braak, E., Schultz, C., & Hanke, J. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017038 · Cited by 51
Self-citationNagy, Z., Hindley, N., Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., Barnetson, L. P. D., Jobst, K. A., & Smith, A. D. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017110 · Cited by 49
Self-citationStaging of Alzheimer-Type Pathology: An Interrater-Intrarater Study
Nagy, Z., Vatter-Bittner, B., Braak, H., Braak, E., Yilmazer, D. M., Schultz, C., & Hanke, J. (1997) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106639 · Cited by 45
Self-citationDuration of neurofibrillary changes in the hippocampal pyramidal neurons
Bobinski, M., Węgiel, J., Tarnawski, M. J., Bobinski, M., de Leon, M. J., Reisberg, ., Miller, D. C., & Wı́sniewski, H. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00441-7 · Cited by 38
Interrater reliability in the neuropathologic diagnosis of Alzheimer's disease
Paulus, W., Bancher, C., & Jellinger, K. A. (1992) · Neurology · doi:10.1212/wnl.42.2.329 · Cited by 38
Treating Alzheimer's and Other Dementias.
Deelman, B. G. (1995) · Springer US · Cited by 35
Rapid, Reliable and Economical Silver Stain for Neurofibrillary Tangles and Senile Plaques
Garvey, W., Fathi, A., Bigelow, F., Jimenez, C. L., & Carpenter, B. F. (1991) · Journal of Histotechnology · doi:10.1179/his.1991.14.1.39 · Cited by 35
Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging
Pallister, C., Jung, S. S., Shaw, I. T., Nalbantoglu, J. N., Gauthier, S. G., & Cashman, N. R. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00207-2 · Cited by 31
Treating Alzheimer's and Other Dementias
Bergener, M., & Finkel, S. I. (1995) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 28
Neurotrophin receptor and tyrosine hydroxylase gene expression in aged sympathetic neurons
Kuchel, G. A., Rowe, W. B., Meaney, M. J., & Richard, C. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00212-6 · Cited by 27
Proposals for Re-evaluation of Current Autopsy Criteria for the Diagnosis of Alzheimer’s Disease
Jellinger, K. A., & Bancher, C. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00071-7 · Cited by 23
Human Postmortem Brain Tissue and 2-mm Tissue Microarrays
Kauppinen, T., MARTIKAINEN, P. M., & Alafuzoff, I. I. (2006) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200609000-00016 · Cited by 22
Self-citationCullen, K. M., Halliday, G. M., Cartwright, H., & Kril, J. J. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0025 · Cited by 20
Neuropathologic diagnosis of Alzheimer disease: consensus between practicing neuropathologists?
Bancher, C., Paulus, W., Paukner, K., & Jellinger, K. A. (1997) · PubMed · Cited by 19
Stains for the Differential Diagnosis of Degenerative Dementias
Muñoz, D. G. (1999) · Biotechnic & Histochemistry · doi:10.3109/10520299909034668 · Cited by 19
Clinical validity of Braak staging in the oldest-old
Jellinger, K. A. (2000) · Acta Neuropathologica · doi:10.1007/s004010051164 · Cited by 16
Beech, R. H., & Davenport, H. (1933) · Stain Technology · doi:10.3109/10520293309116096 · Cited by 15
Churukian, C., Kazee, A. M., Lapham, L., & Eskin, T. (1992) · Journal of Histotechnology · doi:10.1179/his.1992.15.4.299 · Cited by 15
Plasticity and the Spread of Alzheimer's Disease-Like Changes
Ohm, T. G., Glöckner, F., Distl, R., Treiber‐Held, S., Meske, V., & Schönheit, B. (2003) · Neurochemical Research · doi:10.1023/a:1026017206925 · Cited by 10
Dickson, D. W. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00053-5 · Cited by 9
Flowers, D., Harasty, J., Halliday, G., & Kril, J. (1996) · Journal of Histotechnology · doi:10.1179/his.1996.19.1.33 · Cited by 7
Research uses of neuropathological data.
Coleman, P. D. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00059-6 · Cited by 4
[Is the topography of Alzheimer's disease lesions a clue to their pathogenesis?].
Duyckaerts, C. J., Bennecib, M., Grignon, Y., Piette, F., & Hauw, J. (1996) · PubMed · Cited by 2
Research works printed but not linked: 7
- Alzheimer A (1906) Über einen eigenartigen schweren Erkrankungsprozeß der Hirnrinde. Neurolog Centralbl 23:1129–1136
- Bielschowsky M (1902) Die Silberimprägnation der Axenzylinder. Neurol Centralb 13:579–584
- Bielschowsky M (1903) Die Silberimprägnation der Neurofibrillen. Neurol Centralb 21:997–1006
- Bielschowsky M (1904) Die Silberimprägnation der Neurofibrillen. Einige Bemerkungen zu der von mir angegebenen Methode und den von ihr gelieferten Bildern. J Psychol Neurol 3:169–189
- Bielschowsky M (1905) Die Darstellung der Axenzylinder peripherischer Nervenfasern und der Axenzylinder zentraler markhaltiger Nervenfasern. Ein Nachtrag zu der von mir angegebenen Imprägnationsmethode der Neurofibrillen. J Psychol Neurol 4:228–231
- Bielschowsky M (1909) Eine Modifikation meines Silberimprägnations-verfahrens zur Darstellung der Neurofibrillen. J Psychol Neurol 12:135–137
- Duyckaerts C, He Y, Seilhean D, Delaère P, Piette F, Braak H, Hauw JJ (1994) Diagnosis and staging of Alzheimer’s disease in a prospective study involving aged individuals. Neurobiol Aging 15(Suppl 1):140–141
Cited by
Sorted by citations
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
“‘‘Intermediate’’ or ‘‘High’’ AD neuropathologic change (italicized) is considered sufficient explanation for dementia a NFT stage should be determined by the method of Braak [14, 15] b Ab/amyloid plaque score should be determined by the method of Thal et al.”
InfluentialStages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
Self-citationNelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Self-citation
Metadata
- Authors
- Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K.
- Affiliations
- Goethe University Frankfurt (DE)
- Kuopio University Hospital (FI)
- Institut für Neuropathologie (DE)
- Corresponding author
- Braak, Heiko
- Venue
- Acta Neuropathologica
- Published
- 2006-08-12
- Volume
- 112
- Issue
- 4
- Pages
- 389-404
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC3906709
- OpenAlex
- W2093650784
- Cited by
- 3,172
- References
- 101
- Citations by year
- 2026: 218 · 2025: 259 · 2024: 334 · 2023: 254 · 2022: 251 · 2021: 261 · 2020: 228 · 2019: 205 · 2018: 157 · 2017: 135 · 2016: 140 · 2015: 118 · 2014: 134 · 2013: 95 · 2012: 77
- FWCI
- 34.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission (LSHM-CT-2004-503039)
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary pathology, disease staging, AT8 antibody, immunocytochemistry, paraffin sections, silver staining
- MeSH terms
- Alzheimer Disease, Humans, Immunohistochemistry, Amyloid beta-Peptides, Paraffin Embedding, Tissue Fixation, Neurofibrillary Tangles, tau Proteins, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
